Lenvatinib latest price 2023

Lenvatinib belongs to the kinase inhibitor class of drugs. It works by blocking the activity of an abnormal protein that sends a reproduction signal to cancer cells, which helps prevent the spread of cancer cells. Lenvatinib may initially be used to treat a certain type of thyroid cancer that has come back or has spread to other parts of the body and cannot be treated with radioactive iodine.

Lenvatinib is used with everolimus to treat renal cell carcinoma (RCC, a cancer that starts in the kidneys) in people who have been previously treated with another chemotherapy drug, and with pembrolizumab as the initial treatment for advanced renal cell cancer. Lenvatinib is also used to treat hepatocellular carcinoma (HCC; a type of liver cancer that cannot be treated with surgery). Lenvatinib is also used with pembrolizumab to treat a certain type of endometrial cancer (EC) that has spread to other parts of the body, has gotten worse during or after chemotherapy drugs, or cannot be treated with surgery or radiation therapy.

Lenvatinib The brand name of the original drug on the domestic market is Lenvima, and it is covered by Class B medical insurance. The price of each box of 4mg*30 tablets may be more than 3,000 yuan. Lenvatinib original drug currently on the market overseas, specifications 4mg*30 capsules, may cost more than 1,000 yuan per box (the price may fluctuate due to exchange rates). Lenvatinib generic drugs are also produced and marketed overseas. Their drug ingredients are basically the same as those of the original drugs sold domestically and abroad, but the price is cheaper. For example, the price of a box of 4mg*30 tablets produced by a Bangladesh pharmaceutical factory may be around RMB 800 (the price may fluctuate due to exchange rates).